Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies
Alex RD Delbridge, Stephanie Grabow, Andreas Strasser, David L Vaux
Nature Reviews Cancer | NATURE PUBLISHING GROUP | Published : 2016
Awarded by Cancer Council of Victoria
Awarded by Australian National Health and Medical Research Council (NHMRC)
Awarded by Australian National Health and Medical Research Council (NHMRC) (NHMRC SPRF)
Awarded by Leukemia and Lymphoma Society (SCOR)
The authors thank J. M. Adams, S. Cory, P. Bouillet, D. Huang, M. Herold, D. Gray, G. Lessene, P. Colman, R. Kluck, G. Dewson, B. Kile, A. Roberts, L. A. O'Reilly, G. Kelly, C. Vandenberg, B. Aubrey, F. Ke, A. Janic, L. Valente, S. Alvarez-Diaz, A. Kueh, J. Low, L. Rohrbeck, R. Schenk, M. Brennan, R. Salvamoser and B. Yang for insightful discussions. Work in the authors' laboratories is supported by grants and fellowships from the Cancer Council of Victoria (postdoctoral fellowship to S.G., a Sydney Parker Smith postdoctoral research fellowship to A.R.D.D. and grant in aid 1044722 to D.L.V.); a Lady Tata Memorial Trust postdoctoral award (to S.G.); a Leukaemia Foundation Australia postdoctoral fellowship (to S.G.); a Cure Brain Cancer Innovation Grant (to A.S. and S.G.); the Australian National Health and Medical Research Council (NHMRC) (program grant # 1016701 and NHMRC SPRF fellowships 1020363 (to A.S.) and 1020136 (to D.L.V.)); the Leukemia and Lymphoma Society (SCOR grant # 7001-13); the Estate of Anthony (Toni) Redstone OAM; Melbourne International Research Scholarship (University of Melbourne, to S.G.); Melbourne International Fee Remission Scholarship (University of Melbourne, to S.G.); Australian Postgraduate Award (to A. R.D.D.) and Cancer Therapeutics CRC top-up scholarship (to S.G. and A.R.D.D). Work in the authors' laboratories is made possible by operational infrastructure grants through the Australian Government Independent Research Institutes Infrastructure Support (IRISS) and the Victorian State Government OIS.